Intracellular calcium handling in ventricular myocytes from mdx mice

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 292, Issue 2, 2007, Pages

  Williams, Iwan A ^a   Allen, David G ^a  

^a UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Dilated cardiomyopathy; Duchenne muscular dystrophy; Excitation contraction coupling; Stretch activated channels

Indexed keywords

CAFFEINE; CALCIUM ION; DYSTROPHIN; PHOSPHOLAMBAN; RYANODINE RECEPTOR; SERINE; STREPTOMYCIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DISEASE ASSOCIATION; FLUORESCENCE; HEART; HEART FAILURE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; MUSCLE CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SODIUM CALCIUM EXCHANGE; SYMPTOMATOLOGY;

AGE FACTORS; ANIMALS; CAFFEINE; CALCIUM; CALCIUM-BINDING PROTEINS; CARDIAC OUTPUT, LOW; CARDIOMYOPATHY, DILATED; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; FIBROSIS; HEART VENTRICLES; MALE; MICE; MICE, INBRED C57BL; MICE, INBRED MDX; MUSCULAR DYSTROPHY, ANIMAL; MUSCULAR DYSTROPHY, DUCHENNE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; PEPTIDES; PHOSPHORYLATION; RYANODINE RECEPTOR CALCIUM RELEASE CHANNEL; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES; SODIUM-CALCIUM EXCHANGER; SPIDER VENOMS; STREPTOMYCIN; TIME FACTORS; TRPC CATION CHANNELS;

EID: 33846958084     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00688.2006     Document Type: Article

References (65)

1. Alderton JM, Steinhardt RA. How calcium influx through calcium leak channels is responsible for the elevated levels of calcium-dependent proteolysis in dystrophic myotubes. Trends Cardiovasc Med 10: 268-272, 2000.
2. Alloatti G, Gallo MP, Penna C, Levi RC. Properties of cardiac cells from dystrophic mouse. J Mol Cell Cardiol 27: 1775-1779, 1995.
3. 2+ pump and phospholamban in Spodoptera frugiperda (Sf21) cells reveals new insights on ATPase regulation. J Biol Chem 272: 15872-15880, 1997.
4. Bers DM. Excitation-Contraction Coupling and Cardiac Contractile Force. Dordrecht, The Netherlands: Kluwer Academic, 2001.
5. Bia BL, Cassidy PJ, Young ME, Rafael JA, Leighton B, Davies KE, Radda GK, Clarke K. Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of Duchenne muscular dystrophy. J Mol Cell Cardiol 31: 1857-1862, 1999.
6. Bristow MR, Ginsburg R, Minobe W, Cubicciotti RS, Sageman WS, Lurie K, Billingham ME, Harrison DC, Stinson EB. Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 307: 205-211, 1982.
7. Brodde OE. β1- and β2-Adrenoceptors in the human heart: properties, function, and alterations in chronic heart failure. Pharmacol Rev 43: 203-242, 1991.
8. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 287: C817-C833, 2004.
9. Buchwalow IB, Minin EA, Muller FU, Lewin G, Samoilova VE, Schmitz W, Wellner M, Hasselblatt M, Punkt K, Muller-Werdan U, Demus U, Slezak J, Koehler G, Boecker W. Nitric oxide synthase in muscular dystrophies: a re-evaluation. Acta Neuropathol (Berl) 111: 579-588, 2006.
10. 2+ exchanger in cardiac myocytes. Am J Physiol Cell Physiol 257: C147-C152, 1989.
11. Carlson CG. The dystrophinopathies: an alternative to the structural hypothesis. Neurobiol Dis 5: 3-15, 1998.
12. Carrozza JP Jr, Bentivegna LA, Williams CP, Kuntz RE, Grossman W, and Morgan JP. Decreased myofilament responsiveness in myocardial stunning follows transient calcium overload during ischemia and reperfusion. Circ Res 71: 1334-1340, 1992.
13. Chu V, Otero JM, Lopez O, Sullivan MF, Morgan JP, Amende I, Hampton TG. Electrocardiographic findings in mdx mice: a cardiac phenotype of Duchenne muscular dystrophy. Muscle Nerve 26: 513-519, 2002.
14. Clemo HF, Stambler BS, Baumgarten CM. Persistent activation of a swelling-activated cation current in ventricular myocytes from dogs with tachycardia-induced congestive heart failure. Circ Res 83: 147-157, 1998.
15. Cornea RL, Jones LR, Autry JM, Thomas DD. Mutation and phosphorylation change the oligomeric structure of phospholamban in lipid bilayers. Biochemistry 36: 2960-2967, 1997.
16. Craelius W, Chen V, el Sherif N. Stretch activated ion channels in ventricular myocytes. Biosci Rep 8: 407-414, 1988.
17. Disatnik MH, Dhawan J, Yu Y, Beal MF, Whirl MM, Franco AA, Rando TA. Evidence of oxidative stress in mdx mouse muscle: studies of the pre-necrotic state. J Neurol Sci 161: 77-84, 1998.
18. 2+ is elevated at all ages. J Neurol Sci 103: 226-231, 1991.
19. Emery AE. The muscular dystrophies. Lancet 359: 687-695, 2002.
20. Ervasti JM, Campbell KP. Membrane organization of the dystrophinglycoprotein complex. Cell 66: 1121-1131, 1991.
21. Feng J, Schaus BJ, Fallavollita JA, Lee TC, Canty JM Jr. Preload induces troponin I degradation independently of myocardial ischemia. Circulation 103: 2035-2037, 2001.
22. Finsterer J, Stollberger C. The heart in human dystrophinopathies. Cardiology 99: 1-19, 2003.
23. Franco-Obregon A Jr, Lansman JB. Mechanosensitive ion channels in skeletal muscle from normal and dystrophic mice. J Physiol 481: 299-309, 1994.
24. Frigeri A, Nicchia GP, Nico B, Quondamatteo F, Herken R, Roncali L, Svelto M. Aquaporin-4 deficiency in skeletal muscle and brain of dystrophic mdx mice. FASEB J 15: 90-98, 2001.
25. Froehlich JP, Lakatta EG, Beard E, Spurgeon HA, Weisfeldt ML, Gerstenblith G. Studies of sarcoplasmic reticulum function and contraction duration in young adult and aged rat myocardium. J Mol Cell Cardiol 10: 427-438, 1978.
26. Gao WD, Atar D, Liu Y, Perez NG, Murphy AM, Marban E. Role of troponin I proteolysis in the pathogenesis of stunned myocardium. Circ Res 80: 393-399, 1997.
27. Guharay F, Sachs F. Stretch-activated single ion channel currents in tissue-cultured embryonic chick skeletal muscle. J Physiol 352: 685-701, 1984.
28. Hamill OP, McBride DW Jr. The pharmacology of mechanogated membrane ion channels. Pharmacol Rev 48: 231-252, 1996.
29. Head SI, Williams DA, Stephenson DG. Abnormalities in structure and function of limb skeletal muscle fibres of dystrophic mdx mice. Proc R Soc Lond B Biol Sci 248: 163-169, 1992.
30. Howlett SE, Grandy SA, Ferrier GR. Calcium spark properties in ventricular myocytes are altered in aged mice. Am J Physiol Heart Circ Physiol 290: H1566-H1574, 2006.
31. Huang B, Wang S, Qin D, Boutjdir M, and el Sherif N. Diminished basal phosphorylation level of phospholamban in the postinfarction remodeled rat ventricle: role of beta-adrenergic pathway, G(i) protein, phosphodiesterase, and phosphatases. Circ Res 85: 848-855, 1999.
32. 2+ transients of cardiomyocytes from senescent mice peak late and decay slowly. Cell Calcium 34: 271-280, 2003.
33. Jiang MT, Narayanan N. Effects of aging on phospholamban phosphorylation and calcium transport in rat cardiac sarcoplasmic reticulum. Mech Ageing Dev 54: 87-101, 1990.
34. Ju YK, Saint DA, Gage PW. Hypoxia increases persistent sodium current in rat ventricular myocytes. J Physiol 497: 337-347, 1996.
35. Kimura Y, Kurzydlowski K, Tada M, Maclennan DH. Phospholamban inhibitory function is activated by depolymerization. J Biol Chem 272: 15061-15064, 1997.
36. Knyushko TV, Sharov VS, Williams TD, Schoneich C, Bigelow DJ. 3-Nitrotyrosine modification of SERCA2a in the aging heart: a distinct signature of the cellular redox environment. Biochemistry 44: 13071-13081, 2005.
37. Kubo H, Margulies KB, Piacentino V, III, Gaughan JP, Houser SR. Patients with end-stage congestive heart failure treated with beta-adrenergic receptor antagonists have improved ventricular myocyte calcium regulatory protein abundance. Circulation 104: 1012-1018, 2001.
38. Kumar A, Boriek AM. Mechanical stress activates the nuclear factorkappaB pathway in skeletal muscle fibers: a possible role in Duchenne muscular dystrophy. FASEB J 17: 386-396, 2003.
39. 2+ activation of contraction as a consequence of reperfusion-induced cellular calcium overload in ferret hearts. J Clin Invest 79: 950-961, 1987.
40. Lehnart SE, Schillinger W, Pieske B, Prestle J, Just H, Hasenfuss G. Sarcoplasmic reticulum proteins in heart failure. Ann NY Acad Sci 853: 220-230, 1998.
41. Lim CC, Apstein CS, Colucci WS, Liao R. Impaired cell shortening and relengthening with increased pacing frequency are intrinsic to the senescent mouse cardiomyocyte. J Mol Cell Cardiol 32: 2075-2082, 2000.
42. 2+-binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle. Biochim Biophys Acta 1689: 252-258, 2004.
43. Lu S, Hoey A. Age- and sex-associated changes in cardiac beta(1)-adrenoceptors from the muscular dystrophy (mdx) mouse. J Mol Cell Cardiol 32: 1661-1668, 2000.
44. Maroto R, Raso A, Wood TG, Kurosky A, Martinac B, Hamill OP. TRPC1 forms the stretch-activated cation channel in vertebrate cells. Nat Cell Biol 7: 179-185, 2005.
45. Meyer M, Schillinger W, Pieske B, Holubarsch C, Heilmann C, Posival H, Kuwajima G, Mikoshiba K, Just H, Hasenfuss G. Alterations of sarcoplasmic reticulum proteins in failing human dilated cardiomyopathy. Circulation 92: 778-784, 1995.
46. Nigro G, Comi LI, Politano L, Bain RJ. The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy. Int J Cardiol 26: 271-277, 1990.
47. O'Rourke B, Kass DA, Tomaselli GF, Kaab S, Tunin R, Marban E. Mechanisms of altered excitation-contraction coupling in canine tachycardiainduced heart failure. I. Experimental studies. Circ Res 84: 562-570, 1999.
48. Papp Z, van der Velden J, Stienen GJ. Calpain-I induced alterations in the cytoskeletal structure and impaired mechanical properties of single myocytes of rat heart. Cardiovasc Res 45: 981-993, 2000.
49. Paria BC, Malik AB, Kwiatek AM, Rahman A, May MJ, Ghosh S, Tiruppathi C. Tumor necrosis factor-α induces nuclear factor-κB-dependent TRPC1 expression in endothelial cells. J Biol Chem 278: 37195-37203, 2003.
50. Petrof BJ, Shrager JB, Stedman HH, Kelly AM, Sweeney HL. Dystrophin protects the sarcolemma from stresses developed during muscle contraction. Proc Natl Acad Sci USA 90: 3710-3714, 1993.
51. Quinlan JG, Hahn HS, Wong BL, Lorenz JN, Wenisch AS, Levin LS. Evolution of the mdx mouse cardiomyopathy: physiological and morphological findings. Neuromuscul Disord 14: 491-496, 2004.
52. Rohman MS, Emoto N, Takeshima Y, Yokoyama M, Matsuo M. Decreased mAKAP, ryanodine receptor, and SERCA2a gene expression in mdx hearts. Biochem Biophys Res Commun 310: 228-235, 2003.
53. Sande JB, Sjaastad I, Hoen IB, Bokenes J, Tonnessen T, Holt E, Lunde PK, Christensen G. Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. Cardiovasc Res 53: 382-391, 2002.
54. 2+-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92: 3220-3228, 1995.
55. 2+-sensitivity of SERCA 2a in failing human myocardium due to reduced serin-16 phospholamban phosphorylation. J Mol Cell Cardiol 31: 479-491, 1999.
56. Simmerman HK, Jones LR. Phospholamban: protein structure, mechanism of action, and role in cardiac function. Physiol Rev 78: 921-947, 1998.
57. Suchyna TM, Johnson JH, Hamer K, Leykam JF, Gage DA, Clemo HF, Baumgarten CM, Sachs F. Identification of a peptide toxin from Grammostola spatulata spider venom that blocks cation-selective stretch-activated channels. J Gen Physiol 115: 583-598, 2000.
58. Vahl CF, Bonz A, Timek T, Hagl S. Intracellular calcium transient of working human myocardium of seven patients transplanted for congestive heart failure. Circ Res 74: 952-958, 1994.
59. Vandebrouck C, Duport G, Cognard C, Raymond G. Cationic channels in normal and dystrophic human myotubes. Neuromuscul Disord 11: 72-79, 2001.
60. 2+] in left ventricular trabeculae from failing rat hearts. J Physiol 546: 537-550, 2003.
61. Weber KT, Sun Y, Tyagi SC, Cleutjens JP. Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms. J Mol Cell Cardiol 26: 279-292, 1994.
62. Wehling-Henricks M, Jordan MC, Roos KP, Deng B, Tidball JG. Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium. Hum Mol Genet 14: 1921-1933, 2005.
63. Woodruff ML, Sampath AP, Matthews HR, Krasnoperova NV, Lem J, Fain GL. Measurement of cytoplasmic calcium concentration in the rods of wild-type and transducin knock-out mice. J Physiol 542: 843-854, 2002.
64. Woolf PJ, Lu S, Cornford-Nairn RA, Watson M, Xiao XH, Holroyd SM, Brown L, Hoey AJ. Alterations in dihydropyridine receptors in dystrophin-deficient cardiac muscle. Am J Physiol Heart Circ Physiol 290: H2439-H2445, 2006.
65. i and muscle damage in the mdx mouse. J Physiol 562: 367-380, 2005.